BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 34513721)

  • 1. The Use of CRISPR/Cas9 as a Tool to Study Human Infectious Viruses.
    Lin H; Li G; Peng X; Deng A; Ye L; Shi L; Wang T; He J
    Front Cell Infect Microbiol; 2021; 11():590989. PubMed ID: 34513721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
    Yin LJ; Hu SQ; Guo F
    Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge.
    Lee C
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.
    Koujah L; Shukla D; Naqvi AR
    Semin Cell Dev Biol; 2019 Dec; 96():53-64. PubMed ID: 30953741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of CRISPR/Cas9 in Understanding Avian Viruses and Developing Poultry Vaccines.
    Vilela J; Rohaim MA; Munir M
    Front Cell Infect Microbiol; 2020; 10():581504. PubMed ID: 33330126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV.
    Peng C; Lu M; Yang D
    Virol Sin; 2015 Oct; 30(5):317-25. PubMed ID: 26511989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-The ultimate weapon to battle infectious diseases?
    Doerflinger M; Forsyth W; Ebert G; Pellegrini M; Herold MJ
    Cell Microbiol; 2017 Feb; 19(2):. PubMed ID: 27860197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
    Gilani U; Shaukat M; Rasheed A; Shahid M; Tasneem F; Arshad M; Rashid N; Shahzad N
    J Med Virol; 2019 Jan; 91(1):1-13. PubMed ID: 30133783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of CRISPR/Cas9 Technology to HBV.
    Lin G; Zhang K; Li J
    Int J Mol Sci; 2015 Nov; 16(11):26077-86. PubMed ID: 26540039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome.
    Liu X; Hao R; Chen S; Guo D; Chen Y
    J Gen Virol; 2015 Aug; 96(8):2252-2261. PubMed ID: 25904148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR based genome editing and removal of human viruses.
    Chen YC
    Prog Mol Biol Transl Sci; 2021; 179():93-116. PubMed ID: 33785179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections.
    Wahid B; Usman S; Ali A; Saleem K; Rafique S; Naz Z; Ahsan Ashfaq H; Idrees M
    Viral Immunol; 2017 Oct; 30(8):552-559. PubMed ID: 28825529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Hepatitis B Virus with the Help of CRISPR/Cas9 Technology.
    Noor S; Rasul A; Iqbal MS; Ahmed B; Akash MSH; Qadir MI
    Crit Rev Eukaryot Gene Expr; 2020; 30(3):273-278. PubMed ID: 32749114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome editing technologies to fight infectious diseases.
    Trevisan M; Palù G; Barzon L
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1001-1013. PubMed ID: 29090592
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kayesh MEH; Hashem MA; Kohara M; Tsukiyama-Kohara K
    Front Microbiol; 2022; 13():953218. PubMed ID: 35847068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity.
    Mohammadzadeh I; Qujeq D; Yousefi T; Ferns GA; Maniati M; Vaghari-Tabari M
    IUBMB Life; 2020 Aug; 72(8):1603-1621. PubMed ID: 32344465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas Biology and Its Application to Infectious Diseases.
    Strich JR; Chertow DS
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30429256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of CRISPR/Cas9 mediated genome editing in farm animals].
    Xing YY; Yang Q; Ren J
    Yi Chuan; 2016 Mar; 38(3):217-26. PubMed ID: 27001476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.